SCHEMBL25258024

SCHEMBL25258024

N#Cc1ccc(Cl)cc1-c1c[nH]nn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
MAPT P10636 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PSMB8 P28062 1/20 0.40
VCAM1 P19320 1/20 0.37
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
MCL1 Q07820 1/20 0.35
CYP2A6 P11509 1/20 0.34
USP8 P40818 2/20 0.34
USP7 Q93009 2/20 0.34
LRRK2 Q5S007 2/20 0.34
USP47 Q96K76 1/20 0.34
NOS2 P35228 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
EIF4E P06730 1/20 0.34
PRMT5 O14744 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29626672 0.77 GABRG2 (0.43) USP8USP7LRRK2ALDH1A1GABRG2
SCHEMBL2076797 0.77 GABRG2 (0.43) USP8USP7LRRK2ALDH1A1GABRG2
SCHEMBL25830894 0.76 KDM4E (0.44) KDM4EMAPTTDP1PSMB8VCAM1
SCHEMBL28667298 0.76 IDO1 (0.53) KDM4E
Hydrochloric Acid SCHEMBL25378498 0.75 KDM4E (0.43) KDM4EMAPTTDP1PSMB8VCAM1
SCHEMBL25379788 0.73 SCN9A (0.50) KDM4EMCL1PRMT5WDR77SCN9A
SCHEMBL25253462 0.70 SCN9A (0.48) KDM4EMAPTTDP1MEN1ALDH1A1
SCHEMBL25379337 0.70 KDM4E (0.39) KDM4EMAPTTDP1PSMB8VCAM1
SCHEMBL25263600 0.69 SCN9A (0.48) KDM4EMAPTTDP1PSMB8VCAM1
SCHEMBL8106170 0.69 PGR (0.41) MCL1LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552772-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2026-02-17 US disclosed
US-20250115574-A1 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD VIB VZW (BE) 2025-04-10 US disclosed
EP-4452253-A2 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD The Katholieke Universiteit Leuven (BE) 2024-10-30 EP disclosed
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
WO-2023122780-A9 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed
WO-2023122780-A2 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552772-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 KDM4E 516/4885MAPT 1955/4885TDP1 1487/4885
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 KDM4E 1163/4885MAPT 2994/4885TDP1 1073/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 KDM4E 1163/4885MAPT 2994/4885TDP1 1073/4885
US-20250115574-A1 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 KDM4E 1163/4885MAPT 2994/4885TDP1 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.